Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Santen Oy, Niittyhaankatu 20, 33720, Tampere, Finland
Saflutan 15 micrograms/ml eye drops, solution.
| Pharmaceutical Form |
|---|
|
Eye drops, solution (eye drops). A clear, colourless solution, practically free from visible particles with a pH between 5.5 and 6.7, and an osmolality of 260-300 mOsmol/kg. |
One ml of solution contains 15 micrograms of tafluprost.
One drop contains about 0.45 micrograms of tafluprost.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Tafluprost |
Tafluprost is a fluorinated analogue of prostaglandin F2α. Tafluprost acid, the biologically active metabolite of tafluprost, is a highly potent and selective agonist of the human prostanoid FP receptor. |
| List of Excipients |
|---|
|
Glycerol |
Transparent low-density polyethylene (LDPE) bottles with white Aptar OSD (polyethylene, polypropylene, cyclic olefin copolymer) with blue polyethylene cap packed in a PET coated aluminium/polyethylene foil pouch. Each bottle has a fill volume of 3 ml.
The following pack sizes are available: cartons containing 1 or 3 bottles of 3 ml each packed in pouch.
Not all pack sizes may be marketed.
Santen Oy, Niittyhaankatu 20, 33720, Tampere, Finland
PL 16058/0026
11/02/2019
| Drug | Countries | |
|---|---|---|
| SAFLUTAN | Austria, Australia, Brazil, Cyprus, Spain, Croatia, Ireland, Israel, Malta, Mexico, Netherlands, Romania, Tunisia, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
